Evidence map›Paper›PMID 38162520›Full record

ArticleFrontiers in nutrition2023

Safety, efficacy, and impact on gut microbial ecology of a

Maria Rosario Z Capeding, Loudhie Cyd M Phee, Chang Ming, Mario Noti, Karine Vidal, Gilles Le Carrou, A Frézal, Janne Marie Moll, Josef Korbinian Vogt, Pernille Neve Myers and 5 more

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Impact ofFrontiers in nutrition · 2026
    Trial
  4. Trial
  5. Safety and Tolerance ofNutrients · 2025
    Trial
  6. Article
  7. Article
  8. mSphere · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Clinical effects ofFrontiers in nutrition · 2025
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maria Rosario Z CapedingAsian Hospital and Medical Center, Muntinlupa City, Philippines.
Loudhie Cyd M PheeAsian Hospital and Medical Center, Muntinlupa City, Philippines.
Chang MingBiostatistics & Data, Nestlé Research, Lausanne, Switzerland.
Mario NotiNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland.
Karine VidalNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland.
Gilles Le CarrouNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland.
A FrézalNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland.
Janne Marie MollClinical Microbiomics, Copenhagen, Denmark.
Josef Korbinian VogtClinical Microbiomics, Copenhagen, Denmark.
Pernille Neve MyersClinical Microbiomics, Copenhagen, Denmark.
Bjørn Henrik NielsenClinical Microbiomics, Copenhagen, Denmark.
Claire L BoulangéNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland.
Tinu Mary SamuelNestlé Product Technology Center - Nutrition, Société des Produits Nestlé S.A., Vevey, Switzerland.
Bernard BergerNestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., Lausanne, Switzerland.
Colin Ivano CercamondiNestlé Product Technology Center - Nutrition, Société des Produits Nestlé S.A., Vevey, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: This randomized, placebo-controlled, double-blind study conducted in the Philippines included healthy breastfed and/or formula-fed infants (14-21 days old) randomized for 8 weeks to a control group (CG; Results: Non-inferiority in weight gain was demonstrated for Hi-EG and Lo-EG vs. CG. Overall, probiotic supplementation promoted mushy-soft stools, fewer regurgitation episodes, and increased fecal acetate production, which was more pronounced in the exclusively breastfed infants (EBF) and positively correlated with Discussion:

Indexed as

autochthonous strainsBifidobacterium-rich microbiotaB. infantis LMG11588infant growthsafety

Identifiers

PMID38162520
PMCPMC10755859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.